Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Martina Ferranti"'
Autor:
Alfredo Rossi, Martina Ferranti, Francesca Magri, Marco Di Fraia, Gemma Caro, Maria Caterina Fortuna, Marta Muscianese, Simone Michelini, Marta Carlesimo
Publikováno v:
Dermatology Practical & Conceptual, Vol 12, Iss 2 (2022)
Introduction: Currently, the mostly used classifications of androgenetic alopecia (AGA), only provide a macroscopic and subjective description of this disorder, without evaluating trichoscopic features. Objective: The aim of this study is to elabor
Externí odkaz:
https://doaj.org/article/1c040b9271ec4026a11dadfa8a7ebede
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Externí odkaz:
https://doaj.org/article/33cc7aa149c6436995fca995782ee50a
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/887df2c6786b42a0a03e22885d646755
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Externí odkaz:
https://doaj.org/article/7e98d3e375304c6d98bc1793b603b59e
Publikováno v:
In Vivo
Background/aim Autoimmune bullous diseases (AIBDs) of the skin and mucosae include a heterogeneous group of chronic diseases, which could be associated with various comorbidities. The purpose of this study was to evaluate the comorbidity profiles of
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Publikováno v:
BMJ Case Rep
A 68-year-old woman was referred to the unit of dermatology for a large basal cell carcinoma on the chin. She was treated with imiquimod cream 5%, and 4 weeks after she developed isolated and grouped tense serum-filled vesicles and bullae on lips, no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ccadc2859cb8a275637a5eb0dde086
http://hdl.handle.net/11577/3332458
http://hdl.handle.net/11577/3332458
Publikováno v:
BMJ Case Rep
Pemphigus vulgaris is an autoimmune bullous disease that involves the skin and mucous membranes. Current therapies aim to decrease antibody production by means of the use of systemic corticosteroids, immunosuppressive agents and, recently, rituximab,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10987323ec8b15d10fd8dcc0fc15f885
https://europepmc.org/articles/PMC6301621/
https://europepmc.org/articles/PMC6301621/